Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents

7Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Purpose: Osteoporosis is a skeletal disorder characterized by reduced bone mass that results in increased risk of fractures. Pediatric osteoporosis can be caused by monogenic diseases, chronic diseases, and/or their treatment. This study was performed to investigate the effect of pamidronate infusion on osteoporosis in children and adolescents. Methods: This study included 13 unrelated pediatric patients (10 males and 3 females) whose bone mineral density (BMD) z-score was

Cite

CITATION STYLE

APA

Yoon, J. H., Choi, Y., Lee, Y., Yoo, H. W., & Choi, J. H. (2021). Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents. Annals of Pediatric Endocrinology and Metabolism, 26(2), 105–111. https://doi.org/10.6065/apem.2040150.075

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free